Web Desc
Antibodies as Drugs: From B Cell Biology to New Treatments
Scientific Organizers: Paul Carter, Janine Schuurman and Karl Dane Wittrup
Date: February 02 - 06, 2020
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Sponsored by BioLegend, Inc., Compass Therapeutics, Incyte Corporation, MorphoSys AG and Surface Oncology

Supported by a grant from Genentech
Summary of Meeting:
Since the mid-1990s, antibodies have grown steadily into a clinically important pharmaceutical class with over 70 antibody-based drugs approved, predominantly in oncology, autoimmunity and inflammation. As the antibody drug field has expanded and matured in recent years, the field has moved from empirical strategies to deep knowledge-based, designer approaches for which understanding of mechanisms of action is critical; there has also been a trend toward increasingly specialized meetings with a narrow focus such as cancer immunotherapy, bispecifics or B cell biology. In contrast, we are proposing a scientifically diverse program that spans a broad range of different and cutting-edge topics relevant to antibody drug development, including antibodies for infectious disease and antibody pharmacology, topics which are often under-represented at major antibody conferences. Additionally, we have chosen a diverse collection of speakers from junior investigators to seasoned researchers from a wide range of institutions in at least eight different countries. We hope and expect that this approach will stimulate ‘cross-pollination’ between disciplines that span the gamut from basic to translational to clinical sciences with the common theme of antibody drugs for the benefit of patients.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: October 17 2019 details
Discounted Abstract Deadline: October 17 2019 details & pricing
Abstract Deadline: November 5 2019 details & pricing
Discounted Registration Deadline: December 5 2019 details & pricing


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for short talks. Abstracts may be submitted for poster presentations up to 6 weeks prior to meeting start date based on availability


Keystone Symposia thanks our Sponsor for generously supporting this meeting:
BioLegend, Inc.Compass TherapeuticsGenentech, Inc.Incyte CorporationMorphoSys AGSurface Oncology
We gratefully acknowledge additional support from these exhibitors at this conference:
10x Genomics
We gratefully acknowledge additional support for this conference from:
AdipoGen Life SciencesAmerican Association for Cancer Research (AACR)MacroGenics, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Adimab, Inc.

Genentech, Inc.

Genmab A/S

Immatics Biotechnologies GmbH

Light Chain Bioscience
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found